Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 ,inter alia, to consider and approve 1. Audited standalone and ....
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krsnaa Diagnostics has informed the stock exchanges that its Board of Directors will meet on Monday, May 12, 2025. The meeting will consider and approve the audited standalone and consolidated financial results for the quarter and full year ended March 31, 2025 (Q4 FY25 and FY25 results). The Board will also consider recommending a final dividend, if any, for the financial year ended March 31, 2025. This is a standard advance intimation filed under SEBI LODR regulations, and no actual financial numbers have been disclosed yet.
This filing is purely procedural and does not contain results. Shareholders should watch for the actual Q4 and FY25 earnings announcement on or after May 12, 2025, along with any final dividend declaration. The dividend recommendation, if approved, would be the key catalyst for the stock post the announcement.